The development of AOs to induce dystrophin exon skipping was informed by the clear genotype–phenotype correlation, with in-frame genomic deletions typically (but not always) associated with the milder form of Becker muscular dystrophy (BMD) [109]. The gene discussed is DMD; the disease is Becker muscular dystrophy.